Viewing nowCresant 10mg Tablet (Rosuvastatin Calcium)
Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

MFDS item code 200900691 · Notified 2009.01.16 · Insurance code 641904780
Treatment of dyslipidemia, inhibition of atherosclerosis progression, and prevention of cardiovascular disease
This medication is primarily used in patients with hypercholesterolemia and hyperlipidemia. It assists patients with primary hypercholesterolemia, especially those with familial hypercholesterolemia and combined hyperlipidemia, when dietary management and exercise are insufficient. It also reduces the risk of cardiovascular diseases and slows the progression of atherosclerosis. Particularly in children and adolescents aged 10 to 17 years with familial hypercholesterolemia, it is used as an adjunct to diet. It is also effective in patients with dysbetalipoproteinemia. This medication contributes to improving cardiovascular health by reducing the risk of myocardial infarction, stroke, and arterial revascularization.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine, and should continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. Adjust the maintenance dose appropriately at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and the patient's response; the dose may be increased to a maximum of 20 milligrams once daily. 3. Elderly patients : No dosage adjustment is necessary. 4. Patients with renal impairment : No dosage adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering 20 mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment : No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race : Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy : The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this medicine is contraindicated in some of these patients.
2. Pediatric patients with heterozygous familial hypercholesterolemia (ages 10 to 17 years) The usual dose range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses greater than 20 milligrams in pediatric patients.) Adjust the dose individually according to the recommended treatment goal for each patient. Adjust the dose at intervals of 4 weeks or longer. Safety and efficacy in children under 10 years of age have not been established.
This medication should not be used in certain patients. For example, patients with an allergy to this drug or active liver disease should not receive it. Also, it should not be administered to patients with muscular diseases or severe renal impairment, or to women who are pregnant or breastfeeding. This medication contains lactose and is not suitable for patients with lactose intolerance. Patients who consume alcohol heavily or have a history of liver disease should undergo liver function tests before taking this medication and should consult a physician immediately if liver function worsens. Any symptoms such as myalgia or muscle weakness should be reported to medical staff immediately, and muscle enzyme tests should be performed if necessary. This medication may interact with other drugs, so inform healthcare providers of any medications being taken. Special caution is needed when combined with certain antivirals, immunosuppressants, and some antibiotics, as the risk of muscular adverse reactions may increase. Women who can become pregnant should use appropriate contraception during treatment and stop taking the medication immediately if pregnancy is confirmed. There is no specific antidote in case of overdose, so treatment will be symptomatic, and liver function and muscle enzymes should be checked periodically. Additionally, this medication may rarely cause skin rashes or severe allergic reactions, so if there are any skin abnormalities, discontinue use immediately and consult a healthcare professional. Caution is needed when driving or operating machinery, as dizziness may occur.
Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, shortness of breath, diarrhea, ocular myasthenia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lichenoid drug rash, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, increased AST, numbness, sensory abnormalities, chest discomfort, loss of appetite, abdominal distension, syncope, generalized pain, fatigue
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a tightly closed container. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius to ensure the safety of the medication's effectiveness.
Pink round film-coated tablet
30 tablets/box (10 tablets/PTP x 3), 100 tablets/box (10 tablets/PTP x 10), 30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Kyeongbo Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.